← Open Payments lookup

AMBER ARMSTRONG: Open Payments

NPI 1225527344 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$7,271 in 203 payments from 20 companies in 2025. Trend: 2023 $844 · 2024 $4,566 · 2025 $7,271

Food & beverage: $4,293Consulting: $2,970Travel & lodging: $8
CompanyPaymentsAmount
Madrigal Pharmaceuticals16$3,451
ABBVIE INC.42$1,025
PFIZER INC.24$477
Celltrion USA Inc.23$365
Janssen Biotech, Inc.14$300
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$263
GENZYME CORPORATION7$199
Aimmune Therapeutics, Inc.23$190
Medtronic, Inc.2$152
Ipsen Biopharmaceuticals, Inc5$147

Products named: VELSIPITY, TREMFYA, VEGZELMA, DUPIXENT, MAVYRET, XIFAXAN, ZENPEP, REZDIFFRA.

Industry payments across TX — which companies pay providers there.